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Background: Lung cancer stage at diagnosis predicts possible curative treatment. In Denmark and the UK, lung
cancer patients have lower survival rates than citizens in most other European countries, which may partly be
explained by a comparatively longer diagnostic interval in these two countries. In Denmark, a pathway was
introduced in 2008 allowing general practitioners (GPs) to refer patients suspected of having lung cancer directly to
fast-track diagnostics. However, symptom presentation of lung cancer in general practice is known to be diverse
and complex, and systematic knowledge of the routes to diagnosis is needed to enable earlier lung cancer diagnosis
in Denmark. This study aims to describe the routes to diagnosis, the diagnostic activity preceding diagnosis and the
diagnostic intervals for lung cancer in the Danish setting.
Methods: We conducted a national registry-based cohort study on 971 consecutive incident lung cancer patients in
2010 using data from national registries and GP questionnaires.
Results: GPs were involved in 68.3% of cancer patients’ diagnostic pathways, and 27.4% of lung cancer patients were
referred from the GP to fast-track diagnostic work-up. A minimum of one X-ray was performed in 85.6% of all cases
before diagnosis. Patients referred through a fast-track route more often had diagnostic X-rays (66.0%) than patients
who did not go through fast-track (49.4%). Overall, 33.6% of all patients had two or more X-rays performed during the
90 days before diagnosis. Patients whose symptoms were interpreted as non-alarm symptoms or who were not
referred to fast-track were more likely to experience a long diagnostic interval than patients whose symptoms were
interpreted as alarm symptoms or who were referred to fast-track.
Conclusions: Lung cancer patients followed several diagnostic pathways. The existing fast-track pathway must be
supplemented to ensure earlier detection of lung cancer. The high incidence of multiple X-rays warrants a continued
effort to develop more accurate lung cancer tests for use in primary care.
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Lung cancer is a significant health problem worldwide.
It is currently the most common cause of cancer death
in the developed world [1], and earlier diagnosis may
promote curative treatment. Danish lung cancer pa-
tients have very low survival rates compared with pa-
tients from comparable countries [2]. In 2005–2007,
the one-year relative survival for all lung cancers was
35% in Denmark compared with 44% in Sweden [2].
This figure could be explained by later diagnosis of
lung cancer in Denmark as increased waiting time and
diagnostic delay are generally believed to allow tumour
stage progression. Danish patients’ survival deficit may
be related to the degree of cancer awareness and the
extent of diagnostic activity at the level of primary care.
This calls for further investigation of the diagnostic
pathway in Danish lung cancer patients.
A national strategy to improve cancer outcome in
Denmark was introduced in 2008, including, among
others, a fast-track diagnostic pathway for suspected
cancer cases; this implied that patients with specific
symptoms (e.g. sustained coughing) were to be seen at
the hospital within three days after referral [3,4].
Most lung cancer patients present with clinical
symptoms before they are diagnosed with cancer [5],
and evidence suggests that symptoms are often experi-
enced long before the diagnosis is made [6,7]. Yet,
most lung symptoms do not represent underlying can-
cer, and the general practitioner (GP) must therefore
interpret the symptoms and weigh the small risk of
underlying cancer against the likelihood of the symp-
toms reflecting a benign or self-limiting illness [8] and
on this basis decide on the appropriate level of diag-
nostic work-up.
Apart from clinical skills, the GP’s principal diagnos-
tic tool for lung symptoms is a chest X-ray. This tool
is, however, not very accurate, and a false negative X-
ray may even increase the diagnostic interval as about
20% of all lung cancer patients have false negative
chest X-rays before diagnosis [9-11].
A British study found that only 23% of 409 included
lung cancer patients followed the route from symp-
tom presentation in general practice to fast-track re-
ferral, while the rest obtained their diagnosis through
other routes [12]. In order to facilitate earlier lung
cancer diagnosis in general practice, we need to know
more about the GPs’ symptom interpretation, their
diagnostic activity and lung cancer patients’ diagnos-
tic pathways.
The aim of this paper was to describe Danish pa-
tients’ different routes to diagnosis of lung cancer in
general and the pre-diagnostic activities undertaken by
GPs in particular. In addition, we aimed to explore the
diagnostic intervals for specific patient groups.Methods
We conducted a national cohort study on first-time
lung cancer patients, using data from national registers
and questionnaires filled in by GPs. The civil registra-
tion number (CRN), a unique 10-digit personal identifi-
cation number assigned to every Danish citizen, was
used to link registers [13].Setting
The study took place in Denmark in 2010. Danish GPs
act as gatekeepers to the rest of the health-care system,
except for emergencies; and 99% of all Danish citizens
are registered with a general practice which they con-
sult for medical advice.Study population
Patients were identified in the Danish National Patient
Registry (NPR) [14]. The NPR is a national population-
based database containing admission and discharge
dates for all Danish citizens treated at Danish hospitals;
and all recorded diagnoses are classified according to
the International Classification of Diseases (ICD-10).
Patients were included if they met the following in-
clusion criteria: 1) registered in the NPR with ICD-10
code C34.0-9 as the primary diagnosis, 2) diagnosed in
the study period from 1 May 2010 to 31 August 2010,
3) living in Denmark, 4) ≥ 18 years and 5) listed with a
Danish GP. We excluded patients who had previously
been registered with any cancer type, except for non-
melanoma skin cancer (C44), in the Danish Cancer
Registry (DCR) [15]. The sampling of patients has been
described in detail elsewhere [16].Data collection
A questionnaire was sent to the general practice at
which the patient was listed. The questionnaire soli-
cited information about the extent of the GP’s involve-
ment in the lung cancer diagnosis and the key dates in
the diagnostic process. Participating GPs were also
asked to list the symptoms and signs presented by the
patients and to describe how they interpreted these
symptoms. The questionnaire was developed in 2009 by
a group of researchers at the Research Unit for General
Practice, Aarhus University [17]. As no pre-designed
questionnaires for this specific purpose were available,
ad hoc questions were constructed on the basis of pre-
viously used validated items [9,16,18]. In practices with
several GPs, the GP who was most familiar with the pa-
tient was asked to complete the questionnaire on the
basis of the medical records. Non-responders received
a reminder after four weeks. No reimbursement was of-
fered for participation.
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We used the DCR to verify the diagnosis and to obtain
data on tumour stage at diagnosis [15]. The DCR con-
tains information about Danish cancer patients, includ-
ing the date of diagnosis and tumour characteristics.
DCR information on tumour characteristics at diagnosis
rests on a multidisciplinary health-care team’s evaluation
of either pathological (pTNM) or clinical (cTNM) data
[19]. If any of the T, N or M values were missing, we
categorised SCLC as ‘limited’ if the tumour was M0 (no
metastases present) and as ‘extensive’ if the tumour was
M1 (metastases present) regardless of the values (known
or unknown) of other components. We categorised
NSCLC as ‘advanced’ if the TNM stage included values
of T4, N3 or M1 regardless of other components [20]
(Table 1). To adjust for confounding by patient charac-
teristics, we obtained data on comorbidity from the
NPR; these data were based on ICD-10 codes for previ-
ous hospitalisations until the date of diagnosis. The pres-
ence of comorbidity was defined according to the
Charlson Comorbidity Index (CCI) [21,22] and cate-
gorised as ‘low’ (CCI = 0), ‘medium’ (CCI = 1-2) or ‘high’
(CCI ≥ 3). Information about performed X-rays was also
obtained from the NPR. Furthermore, we obtained so-
cioeconomic information from the Danish Civil Registra-
tion System (CSR) [13] and the Danish Integrated
Database for Labour Market Research (IDA).
Variables
The patients were divided into groups depending on
whether or not the GP responded to the questionnaire.
GPs involved in the diagnosis were asked to state
whether the patient had been referred through a fast-Table 1 TNM for NSCLC according to the 7th
classification [23]
T/M N0 N1 N2 N3
T1a (≤2 cm) IA IIA IIIA IIIB
T1b (>2 cm) IA IIA IIIA IIIB
T2a (≤5 cm) IB IIA IIIA IIIB
T2b (>5 cm) IIA IIB IIIA IIIB
T3 (>7 cm) IIB IIIA IIIA IIIB
T3 (invasion) IIB IIIA IIIA IIIB
T3 (same lobe nodules) IIB IIIA IIIA IIIB
T4 (extension) IIIA IIIA IIIB IIIB
T4 (pleural effusion) IV IV IV IV
M1a (ipsilateral lung) IIIA IIIA IIIB IIIB
M1a (contralateral lung) IV IV IV IV
M1b (distant) IV IV IV IV
The T component describes the extent of the primary tumour in terms of both
size and local invasion. The N component describes regional lymph node
involvement and the M component denotes whether distant metastases are
present (M1) or not (M0).track route. Moreover, GPs were asked to rate their in-
terpretation of presented symptoms as either 1) Alarm
symptoms suggestive of cancer (alarm symptoms), 2)
Symptoms suggestive of any serious illness (serious, but
unspecific symptoms) or 3) Vague or ill-defined symp-
toms not directly suggestive of cancer or other serious
illness (vague symptoms).
The primary care intervals and the diagnostic intervals
were calculated by combining data from the DCR and
the questionnaire. The primary care interval was defined
as the time from the first presentation of lung cancer
symptoms in primary care until referral to secondary
care, and the diagnostic interval was defined as the time
from first presentation until final diagnosis [24].
Cancer stage at diagnosis was classified according to
the TNM system (version 6) and dichotomised into local
and advanced disease. A cut-point between stage IIB and
IIIA was chosen as previous studies have documented a
significant difference in mortality between these two
stages [25].
The socioeconomic variables considered in the study
were education and marital status. Education included
basic school and was dichotomised into ‘≤10 years’ and
‘>10 years’ [26]. Marital status was dichotomised into
‘cohabitating’ or ‘living alone’.
Comorbidity was assessed by using the Charlson Co-
morbidity Index (CCI); the index date was set as the day
before the first contact with the GP (for patients for
whom the GP was involved in the diagnosis) or the day
before diagnosis (for patients for whom the GP was not
involved in the diagnosis).
Statistical analyses
Patient groups were compared using Wilcoxon’s rank-
sum test for ordinal or continuous data, including time
intervals, Kruskal-Wallis test for differences between
groups or Pearson’s chi-squared test for nominal or di-
chotomous data. In the analyses for Table 2, patients
with unknown characteristics were treated similarly to
patients with known characteristics, but patients with
unknown characteristics were excluded in the analyses
for Table 3.
Backward cumulative curves for the dates of the latest
and the second-latest X-ray before diagnosis and associ-
ated 95% confidence bands were drawn by applying a
standard Kaplan-Maier procedure and normal approxi-
mation on a reversed time scale.
We used generalised linear models for the binomial
family to calculate the associations between long inter-
vals and gender, age, marital status, education, comor-
bidity, GP interpretation and use of fast-track referral.
Long intervals were defined as the 4th quartile for the
full study population. Prevalence ratios were preferred to
odds ratios, which would tend to overestimate the
Table 2 Characteristics of study population and patients with non-responding GP
GP responders:
GP involved GP not involved P-value All responders Non-responders: P-value
N (%) N (%) N (%) N (%)
All 464 (68.3) 215 (31.7) 690 (71.1) 281 (28.9)
Sex:
Male 265 (57.1) 110 (51.2) 0.1471 379 (54.9) 168 (59.8) 0.1671
Female 199 (42.9) 105 (48.8) 311 (45.1) 113 (40.2)
Age:
Mean 68.5 70.1 0.0691 69.0 69.7 0.1741
18-39 years 3 (0.7) 2 (0.9) 0.0402 5 (0.7) 2 (0.7) 0.4612
40-59 years 89 (19.2) 32 (14.9) 123 (17.8) 45 (16.0)
60-79 years 306 (65.9) 136 (63.3) 448 (64.9) 184 (65.5)
80+ years 66 (14.2) 45 (20.9) 114 (16.6) 50 (17.8)
Education:
≤ 10 years 207 (44.6) 111 (51.6) 0.0822 324 (47.0) 145 (51.6) 0.1052
11-15 years 186 (40.1) 78 (36.3) 266 (38.6) 106 (37.7)
> 15 years 51 (11.0) 18 (8.4) 71 (10.3) 19 (6.8)
Unknown 20 (4.3) 8 (3.7) 29 (4.1) 11 (3.9)
Marital status:
Cohabitating 276 (59.5) 110 (51.2) 0.0422 391 (56.7) 166 (59.1) 0.5072
Living alone 188 (40.5) 105 (48.8) 298 (43.2) 115 (40.9)
Unknown 1 (0.1)
Comorbidity3:
0 283 (61.0) 82 (38.1) 0.0012 367 (53.2) 154 (54.8) 0.5142
1-2 143 (30.8) 91 (42.3) 240 (34.8) 99 (35.2)
3+ 38 (8.2) 42 (19.6) 83 (12.0) 28 (10.0)
TNM stage:
Localised 69 (14.9) 42 (19.5) 0.1232 114 (16.5) 62 (22.1) 0.0422
Advanced 395 (85.1) 173 (80.5) 576 (83.5) 219 (77.9)
1Differences between groups were tested by Wilcoxon’s rank-sum test. 2Differences between groups were tested by the Kruskal-Wallis test. 3Charlson Comorbidity
Index (CCI) from NPR (index date: day before diagnosis).
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was above 20% [27]. Consequently, we chose the loga-
rithm for the link function to facilitate direct estimation
of prevalence ratios. Analysis of time intervals was re-
stricted to patients in whose diagnosis the GP was in-
volved. Estimates are presented with 95% confidence
intervals (95% CIs) when relevant. Data were analysed
using the statistical software Stata 12.0 (StataCorp LP,
TX, USA).
Ethics
The study was approved by the Danish Data Protection
Agency (Ref. no.: 2010-41-4694) and the Danish Health
and Medicines Authority (J. no.: 7-505-29-1484/1 and
Ref. no.: 7-604-04-2/195/EHE). The study did not re-
quire approval from the Committee on Health Research




A total of 990 lung cancer patients were identified in the
NPR. We excluded 14 patients because the diagnosis
could not be validated in the DCR. Five patients regis-
tered with a lung cancer diagnosis in the DCR before 1
January 2010 were also excluded. A questionnaire was
sent to the GPs of the remaining 971 patients; 690
(71.1%) GPs responded (Figure 1). Patients listed with
responding GPs had more advanced tumour stage at
diagnosis (Table 2). Patients whose GPs were not in-
volved in the diagnosis tended to be older and they were
more likely to be living alone and to have a higher co-
morbidity score.
Table 3 Primary care and diagnostic intervals (median in days) for lung cancer patients referred through the GP
Primary care interval Diagnostic interval
N Median IQI P-value PR (95% CI) Unadjusted PR (95% CI) Adjusted N Median IQI P-value PR (95% CI) Unadjusted PR (95% CI) Adjusted
All 429 7 0-30 442 29 12-69
Gender
Men 239 7 0-29 0.171 1 1 248 29 10-69 0.546 1 1
Women 190 11.5 0-30 1.0 (0.7-1.5) 1.1 (0.8-1.6) 194 28 13-73 1.1 (0.8-1.6) 1.2 (0.8-1.7)
Age
18-68 years 226 7 0-24 0.146 1 1 233 23 10-56 0.005 1 1
69+ years 203 12 0-37 1.4 (1.0-2.0) 1.5 (1.0-2.1) 209 34 14-87 1.6 (1.2-2.2) 1.4 (1.0-2.1)
Education1
≤ 10 years 189 13 1-39 0.015 1 1 196 32 15-79 0.022 1 1
> 10 years 221 5 0-25 0.7 (0.5-1.0) 0.8 (0.6-1.1) 227 24 8-65 0.8 (0.6-1.2) 0.9 (0.6-1.2)
Marital status
Living together 255 7 0-30 0.972 1 1 263 28 11-69 0.542 1 1
Living alone 174 8 0-29 1.0 (0.7-1.4) 1.0 (0.7-1.4) 179 30 13-69 1.0 (0.7-1.5) 1.1 (0.7-1.5)
Charlson’s Index2
0 292 8.5 0-31 0.234 1 1 301 27 10-65 0.071 1 1
1-2 112 4 0-26 0.8 (0.5-1.3) 0.8 (0.5-1.2) 114 30 13-73 1.0 (0.7-1.6) 1.0 (0.6-1.5)
3+ 25 17 0-50 1.5 (0.8-2.6) 1.3 (0.8-2.3) 27 61 17-106 2.0 (1.3-3.4) 1.9 (1.2-3.0)
GP’s symptom interpretation
Alarm 135 1 0-7 0.001 1 1 136 15 7-38 0.001 1 1
Serious 143 6 0-21 1.7 (0.9-3.29 1.6 (0.9-3.1) 148 29 9-67 1.7 (1.0-2.9) 1.6 (1.0-2.7)
Vague 149 28 10-62 4.7 (2.7-8.1) 4.8 (2.8-8.2) 156 47 21-89 2.4 (1.5-3.9) 2.4 (1.5-3.9)
Use of fast-track route
Yes 178 7 1-23 0.783 1 1 179 23 11-52 0.019 1 1
No 245 9 0-37 1.5 (1.1-2.2) 1.7 (1.1-2.4) 256 34 12-88 1.8 (1.2-2.7) 1.8 (1.2-2.8)
Only GP-involved patients were included in the analyses. Adjusted and unadjusted associations for long intervals (4th quartile) are presented as prevalence ratios (PRs) with 95% confidence intervals (95% CI).
1Years of education. 2Index date: day before first contact to GP.
Effect of gender, age, education, comorbidity and marital status are mutually adjusted. GP’s symptom interpretation and use of fast-track are adjusted for gender, age, education, comorbidity and marital status.















Figure 1 Routes to diagnosis for consecutive primary lung cancer patients.
Figure 2 Proportion of lung cancer patients with X-ray(s)
performed during the 12 months immediately before diagnosis.
The upper curve (blue) shows the proportion of patients receiving at
least one X-ray before diagnosis, while the lower (red) shows the
proportion of patients receiving at least two X-rays before diagnosis.
The curves should be read backwards from D (time for diagnosis),
implying that approximately 34% of patients receive at least two X-rays
90 days before diagnosis. The bands are 95% confidence intervals.
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GPs were involved in the diagnosis of 464 (68.3%) of the
patients. Fast-track referral was used in 40.9% of the
cases where a GP was involved. In total, 186 of the pa-
tients (27.4% of all patients in the study) started their
route by presenting symptom(s) to the GP and subse-
quently being referred to the fast-track diagnostic
pathway.
Patients whose GP was not involved in the diagnosis
were most often diagnosed at the hospital to which they
were referred for another disease (n = 134, i.e. 63.9%). In
total, 43 (6.3%) of the patients were diagnosed in con-
nection with an emergency admission (Figure 1).
Diagnostic activity
Of all patients, 847 (87.2%) had at least one X-ray and
334 (34.4%) had at least two X-rays performed in the
year preceding diagnosis. Most of the diagnostic activity
occurred the last 90 days before the date of diagnosis
(Figure 2).
Diagnostic activity 90 days prior to diagnosis
During the last 90 days before diagnosis, 831 (85.6%) of
the patients had at least one X-ray performed and 326
(33.6%) had at least two. No differences were found in
the number of performed X-rays between GP responders
and GP non-responders (Figure 3) (p = 0.238) or be-
tween GPs involved in the diagnosis and non-involvedGPs (p = 0.550). The proportion of patients who had one
X-ray performed was higher among patients referred to
fast-track (122 (66.0%, 95% CI: 58.3-73.4)) than among
patients who were not referred to fast-track (133 (49.4%,
95% CI: 43.3-55.6)). The corresponding risk difference
(RD) was 16.1 (95% CI: 7.1-25.2, p = 0.001) (Figure 3).
Figure 3 Number of X-rays performed during the 90 days before diagnosis, depicted as percentages of patients with ‘zero’,’one’,’ two’
or ’three or more’ X-rays performed prior to diagnosis. The columns refer to the patients in different routes to diagnosis as illustrated in
Figure 1, except for the three columns with GP symptom interpretation. 1Percentage of all patients for whom the GP responded. 2Percentage of
all patients for whom the GP was involved in the diagnosis (10 missings).
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was higher in patients whose symptoms were interpreted
as ‘serious, but unspecific’ (35.9%, 95% CI: 28.4-44.1)
than in patients whose symptoms were described as
‘alarm symptoms’ (22.1%, 95% CI: 15.6-30.0; RD 13.8,
95% CI: 3.6-24.1 (p = 0.010)). The proportion of patients
who had two or more X-rays was higher among patients
with co-morbidity (CCI > 0) (41.6%, 95% CI: 37.0-46.3)
than among patients with no co-morbidity (CCI = 0)
(26.8%, 95% CI: 23.2-30.8); RD 14.7, 95% CI: 8.8-20.6
(p = 0.001).
Primary care interval and diagnostic interval
The overall median primary care interval was 7 days
(interquartile interval (IQI): 0–30); the median diagnos-
tic interval was 29 days (IQI: 12–69).
Patient-related factors
The median primary care interval and the diagnostic in-
tervals were longer among patients with the lowest edu-
cational level (Table 3) than among better educated
patients. Older age was statistically significantly associ-
ated with longer intervals of both primary care interval
of >30 days and diagnostic interval of ≥69 days.
GP-related factors
The median primary care interval and the diagnostic
interval were statistically significantly shorter if the GP
suspected cancer or a serious disease (Table 3). Patients
referred to a fast-track route experienced a statisticallysignificantly shorter median diagnostic interval than pa-
tients not referred to a fast-track route. Patients with ad-
vanced disease stages had a statistically significantly
shorter diagnostic interval than patients with localised
disease, but, notably, not a longer primary care interval
(median diagnostic interval: 26 vs. 40 days (p = 0.024),
median primary care interval: 7 vs. 8 days (p = 0.462)).
A long primary care interval (adjusted PR: 4.8 (2.8-
8.2)) and a long diagnostic interval (adjusted PR: 2.4
(1.5-3.9) were more likely if the GP interpreted the
symptoms as ‘vague’ than if the GP interpreted the
symptoms as ‘alarm’ symptoms (Table 3).
Discussion
Main findings
In a setting where GPs serve as gatekeepers to specia-
lised medical care, including fast-track cancer diagnostic
pathways, two thirds of lung cancer patients were seen
in general practice before they were diagnosed with can-
cer; one fourth of identified lung cancer patients were
diagnosed through the fast-track route.
The GP assessed the primary care interval to be longer
than one month in one fourth of all lung cancer pa-
tients, and the diagnostic interval was above 69 days.
The length of the diagnostic interval was associated with
patient age, GP interpretation of symptoms and referral
to the fast-track pathway.
The number of patients who had a chest X-ray was
higher among those who were diagnosed through the
fast-track pathway than among those who were not,
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an entrance to the fast-track pathway over basing their
clinical assessment on symptoms alone. Patients who
bypassed the fast-track pathway were more likely to have
either none or more than two X-rays than referred pa-
tients. Furthermore, if the GP interpreted the symptoms
as ‘serious, but unspecific’, the proportion of patients
who had two or more X-rays was higher than if the
symptoms were interpreted as ‘alarm symptoms’. This
may imply that these patients are more difficult to diag-
nose and that the preceding diagnostic activity did not
reveal the lung cancer. Moreover, almost half of the
acutely admitted patients had two or more X-rays, which
could indicate that these patients were seen and investi-
gated in primary care, but that no cancer was identified.
Notably, we found that one third of the patients had at
least two X-rays performed within the last 90 days be-
fore being diagnosed; this suggests that some of these
patients could have had a false negative test. This finding
definitely calls for further research to test whether the
use of imaging with a higher sensibility for lung cancer
implies that fewer tests are needed. We would recom-
mend a randomised controlled trial on better access to a
technologically upgraded investigation, e.g. low-dose CT.
Strength and weaknesses
This study encompassed the entire population of con-
secutive, newly diagnosed lung cancer patients in
Denmark identified through a valid hospital registry.
The large number of included patients ensured a high
statistical precision. The response rate of 71.1% is very
satisfactory. If non-responding GPs were reluctant to re-
spond because of long primary care intervals, our results
are underestimating the actual intervals. GPs could also
have chosen not to respond because they were not in-
volved in the diagnostic pathway; the diagnostic intervals
may then be shorter for these patients because they are
diagnosed in hospitals in connection with investigation
for another disease. This would imply that the overall in-
tervals were overestimated.
Recall bias could be introduced when GPs knew that
the patient was diagnosed with lung cancer because this
knowledge could influence the GP’s assessment of e.g.
the date of first presentation, the symptoms and their in-
terpretation. To minimise this bias, the GPs were asked
to use their electronic records and the discharge letters
from the hospitals. If recall bias made the GP underesti-
mate the length of intervals in relation to symptom pres-
entation, such bias would tend to underestimate the
association between the time intervals and non-alarm
symptoms.
The date of diagnosis was defined as the day when the
diagnosis was initially made in connection with hospital-
isation or an outpatient visit. Thus, the diagnosticintervals are shorter than if we had used the date of
histological verification of the diagnosis. However, as we
wanted to examine the number of GP-initiated X-rays
performed before the diagnosis, our definition of diag-
nostic interval increased the validity of the diagnostic
procedure by being a truly pre-diagnostic activity.
Since we had no indication as to why X-rays were per-
formed, we may have overestimated the diagnostic activity
as some X-rays may have been performed for non-cancer
reasons, e.g. due to pneumonia. Still, also in these in-
stances, the GPs would intend to rule out the possibility of
cancer.
Small cell lung cancer, which grows more rapidly than
other lung cancers, comprised 8-10% of all cases. The
diagnostic intervals for this type of cancer may be
shorter than for other cancers as more alarm symptoms
tend to be present than in non-small cell lung cancer.
However, we did not stratify for this as the type is not
known by the GP at presentation.
Generalisability
We included a well-defined study population. However,
non-response bias should be considered when generalis-
ing the results. Furthermore, the findings should be
interpreted carefully in view of the differences in health-
care systems around the world, e.g. levels of gatekeeping,
fast-track referrals and access to X-ray services.
Comparison with other studies
Our finding is comparable to that of a British retrospect-
ive study of 220 lung cancer patients [28] of whom 61%
were referred from primary care to specialist investiga-
tion. In line with our findings, another British study
from 2012 found that 24% of lung cancer patients were
diagnosed through fast-track referral [29]. However, in-
patient evaluation was found to account for only 4%,
whereas 39% of the patients were diagnosed through
emergency routes. The differences could be explained by
the algorithm used to identify pathways as we were able
to detect if patients were already registered in a hospital-
based pathway. This hypothesis is supported by a British
study from 2007 reporting results similar to ours and in-
cluding emergency referrals in 5% and fast-track refer-
rals in 23% of the cases [12].
A British study [28] reported much longer primary
care intervals than our study (52 (IQI: 7–243)), which
can be explained by differences in study designs. We
used a GP questionnaire, whereas the British study used
research assistants to scrutinise the medical records for
nine predefined lung symptoms. The impact of this dif-
ference in study design has also been shown for colorec-
tal cancer [30].
A Danish study from 2006 [9], i.e. prior to the introduc-
tion of fast-track referral in Denmark, reported longer
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(IQI:10–63)) and secondary care (58 (IQI:42–70)). This
may indicate that the introduction of fast-track pathways
and the increased focus on early cancer detection in
Denmark has had some effect.
We found that 85% of all patients had an X-ray during
the 12 months immediately before diagnosis. This figure
is higher than the corresponding figure in a British study
from 2005, where 164 of 247 (66%) lung cancer patients
had at least one chest X-ray requested from primary care
in the year before the diagnosis [11]. Of all lung cancer
patients, 15% had no X-ray. The possible lack of diagnos-
tic activity before the diagnosis of lung cancer could be at-
tributable to patients not seeing the GP or patient and/or
GP unawareness of symptoms. A British interview-based
study found that patients extensively framed their symp-
toms of lung cancer as ‘normal features of lifestyle and
ageing processes’ [31].
At least one third of patients had two or more X-rays
during the three months preceding diagnosis, and some
of these could have been negative X-rays. This finding
confirms earlier research [9-11] and indicates a need for
a more critical use of X-rays in patients suspected of
having lung cancer. The number of patients who had an
X-ray performed was higher among those who referred
to a fast-track pathway than among other lung cancer
patients, and this fact may cause concern. If the GPs pri-
marily use the fast track after a suspicious X-ray, the ra-
ther large number of false negative X-rays could explain
why so few patients are referred to the fast-track path-
way, which may ultimately lead to delayed diagnosis.
Conclusion
Lung cancer patients follow various routes to diagnosis,
and only 25% of the included patients were diagnosed
through the fast-track route from general practice. Al-
though many patients are seen in general practice, exist-
ing cancer may not be identified quickly. Fast-track
pathways do not seem sufficient to ensure and support
earlier lung cancer diagnosis, wherefore additional path-
ways are needed. GPs must be provided with better tools
for assessment of lung cancer risk and investigation of
early symptoms. The large number of repeated X-rays in
patients without alarm symptoms and with comorbidity
makes a strong case for testing of better diagnostic tools
(e.g. low-dose CT scans) in a primary care setting. Pa-
tients with lower socioeconomic status, elderly patients
and patients with comorbidity tended to have longer in-
tervals. Identification of these three target groups is im-
portant to ensure shorter clinical pathways in the future
and for healthcare planning in general.
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